<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Olyha SJ</submitter><funding>G. Harold and Leila Y. Mathers Charitable Foundation</funding><funding>Kenneth Rainin Foundation</funding><funding>Leona M. and Harry B. Helmsley Charitable Trust</funding><funding>Yale University</funding><funding>NIDDK NIH HHS</funding><funding>National Institute of Diabetes and Digestive and Kidney Diseases</funding><funding>NIAID NIH HHS</funding><funding>National Institutes of Health</funding><funding>NIAMS NIH HHS</funding><funding>NIH HHS</funding><funding>Canadian Institutes of Health Research</funding><funding>CIHR</funding><pagination>44</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10929603</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>44(2)</volume><pubmed_abstract>Defining monogenic drivers of autoinflammatory syndromes elucidates mechanisms of disease in patients with these inborn errors of immunity and can facilitate targeted therapeutic interventions. Here, we describe a cohort of patients with a Behçet's- and inflammatory bowel disease (IBD)-like disorder termed "deficiency in ELF4, X-linked" (DEX) affecting males with loss-of-function variants in the ELF4 transcription factor gene located on the X chromosome. An international cohort of fourteen DEX patients was assessed to identify unifying clinical manifestations and diagnostic criteria as well as collate findings informing therapeutic responses. DEX patients exhibit a heterogeneous clinical phenotype including weight loss, oral and gastrointestinal aphthous ulcers, fevers, skin inflammation, </pubmed_abstract><journal>Journal of clinical immunology</journal><pubmed_title>"Deficiency in ELF4, X-Linked": a Monogenic Disease Entity Resembling Behcet's Syndrome and Inflammatory Bowel Disease.</pubmed_title><pmcid>PMC10929603</pmcid><funding_grant_id>S10 OD030363</funding_grant_id><funding_grant_id>R01 AI150913</funding_grant_id><funding_grant_id>RC2 DK118640</funding_grant_id><funding_grant_id>U19 AI089992</funding_grant_id><funding_grant_id>KRA000114</funding_grant_id><funding_grant_id>T32 AR007107</funding_grant_id><pubmed_authors>Lucena Soto JM</pubmed_authors><pubmed_authors>Warner N</pubmed_authors><pubmed_authors>Dalm VASH</pubmed_authors><pubmed_authors>Tyler PM</pubmed_authors><pubmed_authors>Sheikha H</pubmed_authors><pubmed_authors>Alam F</pubmed_authors><pubmed_authors>Rodriguez-Martinez A</pubmed_authors><pubmed_authors>Muise AM</pubmed_authors><pubmed_authors>Catanzaro J</pubmed_authors><pubmed_authors>Rothermel H</pubmed_authors><pubmed_authors>Lakhani SA</pubmed_authors><pubmed_authors>van Rossum AMC</pubmed_authors><pubmed_authors>Bucklin ML</pubmed_authors><pubmed_authors>Neth O</pubmed_authors><pubmed_authors>Hoppenreijs EPAH</pubmed_authors><pubmed_authors>Jones KM</pubmed_authors><pubmed_authors>Moran CJ</pubmed_authors><pubmed_authors>DiGiacomo DV</pubmed_authors><pubmed_authors>Fiedler K</pubmed_authors><pubmed_authors>Olbrich P</pubmed_authors><pubmed_authors>O'Connor SK</pubmed_authors><pubmed_authors>Uthaya Kumar DB</pubmed_authors><pubmed_authors>Lucas CL</pubmed_authors><pubmed_authors>Montgomery RR</pubmed_authors><pubmed_authors>van der Made CI</pubmed_authors><pubmed_authors>Hoischen A</pubmed_authors><pubmed_authors>Kribis M</pubmed_authors><pubmed_authors>Konnikova L</pubmed_authors><pubmed_authors>Du H</pubmed_authors><pubmed_authors>Olyha SJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>"Deficiency in ELF4, X-Linked": a Monogenic Disease Entity Resembling Behcet's Syndrome and Inflammatory Bowel Disease.</name><description>Defining monogenic drivers of autoinflammatory syndromes elucidates mechanisms of disease in patients with these inborn errors of immunity and can facilitate targeted therapeutic interventions. Here, we describe a cohort of patients with a Behçet's- and inflammatory bowel disease (IBD)-like disorder termed "deficiency in ELF4, X-linked" (DEX) affecting males with loss-of-function variants in the ELF4 transcription factor gene located on the X chromosome. An international cohort of fourteen DEX patients was assessed to identify unifying clinical manifestations and diagnostic criteria as well as collate findings informing therapeutic responses. DEX patients exhibit a heterogeneous clinical phenotype including weight loss, oral and gastrointestinal aphthous ulcers, fevers, skin inflammation, </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jan</publication><modification>2026-06-01T17:54:38.593Z</modification><creation>2025-04-06T01:15:34.493Z</creation></dates><accession>S-EPMC10929603</accession><cross_references><pubmed>38231408</pubmed><doi>10.1007/s10875-023-01610-8</doi></cross_references></HashMap>